Get the Stockscreener App
0.00
100.00%
-4.00
Inozyme Pharma Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Inozyme Pharma Inc is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting bone health and blood vessel function. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. Its product candidate, INZ-701, is a soluble, recombinant, genetically engineered fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 deficiencies.
See More
Previous Close:
$4.00
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$256.96M
Revenue:
-
Net Income/Loss:
$-71.17M
P/E Ratio:
0.00
EPS:
-1.39
Net Cash Flow:
$-70.97M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$5.59
Inozyme Pharma Inc Stock (INZY) Company Profile
Name
Inozyme Pharma Inc
Sector
Industry
Phone
857-330-4340
Address
321 SUMMER STREET, BOSTON
Compare INZY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INZY
Inozyme Pharma Inc
|
0.00 | 256.96M | 0 | -71.17M | -70.97M | -1.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
403.30 | 104.83B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
600.00 | 63.59B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.35 | 60.43B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
800.00 | 48.45B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
343.87 | 37.91B | 4.56B | -176.77M | 225.30M | -1.7177 |
Inozyme Pharma Inc Stock (INZY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-12-24 | Initiated | Raymond James | Outperform |
| Sep-12-24 | Initiated | Stifel | Buy |
| Aug-13-24 | Resumed | Jefferies | Buy |
| May-30-24 | Initiated | Wells Fargo | Overweight |
| Mar-23-23 | Upgrade | Jefferies | Hold → Buy |
| May-26-22 | Initiated | Jefferies | Hold |
| Feb-07-22 | Initiated | H.C. Wainwright | Buy |
| Nov-29-21 | Initiated | Needham | Buy |
| Aug-18-20 | Initiated | BofA Securities | Buy |
| Aug-18-20 | Initiated | Cowen | Outperform |
| Aug-18-20 | Initiated | Piper Sandler | Overweight |
| Aug-18-20 | Initiated | Wedbush | Outperform |
View All
Inozyme Pharma Inc Stock (INZY) Latest News
Custom watchlist performance reports with Inozyme Pharma Inc.2025 Trading Volume Trends & Daily Profit Maximizing Tips - newser.com
What Fibonacci levels say about Inozyme Pharma Inc. reboundCEO Change & Daily Stock Trend Reports - newser.com
Intraday pattern recognizer results for Inozyme Pharma Inc.Weekly Risk Report & Free Verified High Yield Trade Plans - newser.com
Inozyme Pharma Inc. stock prediction for this weekTrend Reversal & High Conviction Trade Alerts - newser.com
Real time breakdown of Inozyme Pharma Inc. stock performanceWeekly Market Summary & Momentum Based Trading Ideas - newser.com
Using data tools to time your Inozyme Pharma Inc. exit2025 Buyback Activity & Consistent Profit Focused Trading Strategies - newser.com
What drives Inozyme Pharma Inc stock priceMarket Sentiment Indicators & Join 100,000+ Investors Already Learning - earlytimes.in
Has Inozyme Pharma Inc. found a price floorQuarterly Market Summary & Risk Controlled Stock Pick Alerts - newser.com
Is Inozyme Pharma Inc a good long term investmentEarnings Season Recap & Double Digit Wealth Tips - earlytimes.in
Can Inozyme Pharma Inc. hit a new high this monthMarket Activity Recap & Precise Swing Trade Entry Alerts - newser.com
Tools to assess Inozyme Pharma Inc.’s risk profileDividend Hike & Momentum Based Trading Ideas - newser.com
Forecasting Inozyme Pharma Inc. price range with options dataPortfolio Gains Summary & Advanced Technical Analysis Signals - newser.com
Aug Momentum: What dividend growth rate does Inozyme Pharma Inc offer2025 Trading Recap & Free Community Supported Trade Ideas - خودرو بانک
Fed Watch: Is Inozyme Pharma Inc. still a buy after recent gainsWeekly Trend Report & Weekly Watchlist for Hot Stocks - خودرو بانک
Inozyme Pharma Inc. stock chart pattern explainedJuly 2025 Opening Moves & Advanced Technical Signal Analysis - newser.com
Earnings Risk: Is Inozyme Pharma Inc benefiting from innovation trendsMarket Growth Review & Low Drawdown Investment Strategies - khodrobank.com
Resistance Check: Is Inozyme Pharma Inc stock a good pick for beginnersPortfolio Profit Report & Stepwise Trade Signal Implementation - خودرو بانک
can inozyme pharma inc. hit a new high this monthQuarterly Trade Summary & Weekly Consistent Profit Watchlists - newser.com
When is the best time to exit Inozyme Pharma Inc.July 2025 Snapshot & Reliable Intraday Trade Alerts - newser.com
S P Trends: Can Inozyme Pharma Inc expand its profit marginsJuly 2025 Highlights & Safe Entry Point Identification - خودرو بانک
Inozyme Pharma Inc Stock (INZY) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.68%
0.38%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):